Literature DB >> 27143420

Presenilin 1 promotes trypsin-induced neuroprotection via the PAR2/ERK signaling pathway. Effects of presenilin 1 FAD mutations.

Angeliki M Nikolakopoulou1, Anastasios Georgakopoulos2, Nikolaos K Robakis3.   

Abstract

Mutants of presenilin 1 (PS1) increase neuronal cell death causing autosomal-dominant familial Alzheimer's disease (FAD). Recent literature shows that treatment of neuronal cultures with low concentrations of trypsin, a member of the serine family of proteases, protects neurons from toxic insults by binding to the proteinase-activated receptor 2 and stimulating survival kinase extracellular signal-regulated kinase (ERK 1/2). Other studies show that PS1 is necessary for the neuroprotective activity of specific neurotrophic factors, such as brain-derived neurotrophic factor, against excitotoxicity and oxidative stress. Here, we show that treatment of mouse cortical neuronal cultures with trypsin activates ERK1/2 and protects neurons against glutamate excitoxicity. The trypsin-dependent ERK activation and neuroprotection requires both alleles of PS1 because neither PS1 knockout nor PS1 hemizygous neuronal cultures can use exogenous trypsin to activate ERK1/2 or increase neuronal survival. The protective effect of PS1 does not depend on its γ-secretase activity because inhibitors of γ-secretase have no effect on trypsin-mediated neuroprotection. Importantly, cortical neuronal cultures either heterozygous or homozygous for PS1 FAD mutants are unable to use trypsin to activate ERK1/2 and rescue neurons from excitotoxicity, indicating that FAD mutants inhibit trypsin-dependent neuroprotection in an autosomal-dominant manner. Furthermore, our data support the theory that PS FAD mutants increase neurodegeneration by inhibiting the ability of neurons to use cellular factors as protective agents against toxic insults.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Familial Alzheimer's disease; Neuroprotection; Neurotoxicity; Presenilin 1; Proteinase-activated receptor 2

Mesh:

Substances:

Year:  2016        PMID: 27143420      PMCID: PMC4857890          DOI: 10.1016/j.neurobiolaging.2016.02.028

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  45 in total

1.  Characterization of proteinase-activated receptor 2 signalling and expression in rat hippocampal neurons and astrocytes.

Authors:  Trevor J Bushell; Robin Plevin; Stuart Cobb; Andrew J Irving
Journal:  Neuropharmacology       Date:  2006-01-20       Impact factor: 5.250

2.  Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease.

Authors:  Amir Afkhami-Goli; Farshid Noorbakhsh; Avril J Keller; Nathalie Vergnolle; David Westaway; Jack H Jhamandas; Patricia Andrade-Gordon; Morley D Hollenberg; Hosseinali Arab; Richard H Dyck; Christopher Power
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

3.  Activated microglia enhance neurogenesis via trypsinogen secretion.

Authors:  Angeliki M Nikolakopoulou; Ranjan Dutta; Zhihong Chen; Robert H Miller; Bruce D Trapp
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

4.  Exogenous kallikrein enhances neurogenesis and angiogenesis in the subventricular zone and the peri-infarction region and improves neurological function after focal cortical infarction in hypertensive rats.

Authors:  Li Ling; Qinghua Hou; Shihui Xing; Jian Yu; Zhong Pei; Jinsheng Zeng
Journal:  Brain Res       Date:  2008-03-19       Impact factor: 3.252

5.  Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy.

Authors:  Anneli Lauhio; Timo Sorsa; Ravi Srinivas; Mathias Stenman; Taina Tervahartiala; Ulf-Håkan Stenman; Carola Grönhagen-Riska; Eero Honkanen
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

6.  Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling.

Authors:  Anastasios Georgakopoulos; Claudia Litterst; Enrico Ghersi; Lia Baki; ChiJie Xu; Geo Serban; Nikolaos K Robakis
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

7.  Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1.

Authors:  Meenakshisundaram Thiyagarajan; José A Fernández; Steven M Lane; John H Griffin; Berislav V Zlokovic
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

Review 8.  Frontotemporal lobar degeneration through loss of progranulin function.

Authors:  Michel Goedert; Maria Grazia Spillantini
Journal:  Brain       Date:  2006-11       Impact factor: 13.501

9.  GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling.

Authors:  Francesca Boscia; Carla Lucia Esposito; Antonella Di Crisci; Vittorio de Franciscis; Lucio Annunziato; Laura Cerchia
Journal:  PLoS One       Date:  2009-08-03       Impact factor: 3.240

10.  Presenilins are essential for regulating neurotransmitter release.

Authors:  Chen Zhang; Bei Wu; Vassilios Beglopoulos; Mary Wines-Samuelson; Dawei Zhang; Ioannis Dragatsis; Thomas C Südhof; Jie Shen
Journal:  Nature       Date:  2009-07-30       Impact factor: 49.962

View more
  9 in total

Review 1.  Intermittent hypoxia training: Powerful, non-invasive cerebroprotection against ethanol withdrawal excitotoxicity.

Authors:  Marianna E Jung; Robert T Mallet
Journal:  Respir Physiol Neurobiol       Date:  2017-08-12       Impact factor: 1.931

Review 2.  Presenilin 1 Regulates Membrane Homeostatic Pathways that are Dysregulated in Alzheimer's Disease.

Authors:  Carol A Deaton; Gail V W Johnson
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway.

Authors:  Mohamed Gamal El-Din Ewees; Mohamed Sadek Abdel-Bakky; Asmaa Mostafa Ahmed Bayoumi; Ali Ahmed Abo-Saif; Waleed Mohammad Altowayan; Khalid Saad Alharbi; Basim Anwar Shehata Messiha
Journal:  J Adv Res       Date:  2021-01-05       Impact factor: 10.479

4.  The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility.

Authors:  Hendrik Ungefroren; David Witte; Christian Fiedler; Thomas Gädeken; Roland Kaufmann; Hendrik Lehnert; Frank Gieseler; Bernhard H Rauch
Journal:  Int J Mol Sci       Date:  2017-12-20       Impact factor: 5.923

5.  Presenilin 1 deficiency suppresses autophagy in human neural stem cells through reducing γ-secretase-independent ERK/CREB signaling.

Authors:  Cheong-Meng Chong; Minjing Ke; Yuan Tan; Zhijian Huang; Ke Zhang; Nana Ai; Wei Ge; Dajiang Qin; Jia-Hong Lu; Huanxing Su
Journal:  Cell Death Dis       Date:  2018-08-29       Impact factor: 8.469

Review 6.  Presenilins as Drug Targets for Alzheimer's Disease-Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development.

Authors:  R Scott Duncan; Bob Song; Peter Koulen
Journal:  Int J Mol Sci       Date:  2018-05-31       Impact factor: 5.923

Review 7.  Non-coding RNA influences in dementia.

Authors:  Duncan Ayers; Charles Scerri
Journal:  Noncoding RNA Res       Date:  2018-09-29

8.  Host neuronal PRSS3 interacts with enterovirus A71 3A protein and its role in viral replication.

Authors:  Patthaya Rattanakomol; Potjanee Srimanote; Pongsri Tongtawe; Onruedee Khantisitthiporn; Oratai Supasorn; Jeeraphong Thanongsaksrikul
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

9.  The influence of two functional genetic variants of GRK5 on tau phosphorylation and their association with Alzheimer's disease risk.

Authors:  Yuan Zhang; Jianghao Zhao; Mingkang Yin; Yujie Cai; Shengyuan Liu; Yan Wang; Xingliang Zhang; Hao Cao; Ting Chen; Pengru Huang; Hui Mai; Zhou Liu; Hua Tao; Bin Zhao; Lili Cui
Journal:  Oncotarget       Date:  2017-08-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.